Does SUMATRIPTAN Cause Hyperreflexia? 38 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Hyperreflexia have been filed in association with SUMATRIPTAN (sumatriptan succinate). This represents 0.2% of all adverse event reports for SUMATRIPTAN.
38
Reports of Hyperreflexia with SUMATRIPTAN
0.2%
of all SUMATRIPTAN reports
0
Deaths
35
Hospitalizations
How Dangerous Is Hyperreflexia From SUMATRIPTAN?
Of the 38 reports, 35 (92.1%) required hospitalization, and 28 (73.7%) were considered life-threatening.
Is Hyperreflexia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SUMATRIPTAN. However, 38 reports have been filed with the FAERS database.
What Other Side Effects Does SUMATRIPTAN Cause?
Drug ineffective (2,941)
Product physical issue (2,349)
Application site erythema (1,875)
Drug dose omission (1,711)
Product quality issue (1,269)
Application site pain (1,217)
Migraine (978)
Headache (914)
Product complaint (718)
Nausea (702)
What Other Drugs Cause Hyperreflexia?
QUETIAPINE (192)
SERTRALINE (174)
VENLAFAXINE (143)
BUPROPION (131)
FLUOXETINE (124)
ESCITALOPRAM OXALATE (116)
LAMOTRIGINE (114)
DULOXETINE (105)
LITHIUM (98)
TRAMADOL (78)
Which SUMATRIPTAN Alternatives Have Lower Hyperreflexia Risk?
SUMATRIPTAN vs SUMATRIPTAN\SUMATRIPTAN
SUMATRIPTAN vs SUMAVEL DOSEPRO
SUMATRIPTAN vs SUNITINIB
SUMATRIPTAN vs SUNITINIB MALATE
SUMATRIPTAN vs SUTENT